TAK1 blockade as a therapy for retinal neovascularization-Reference-Cited by-同舟云学术

TAK1 blockade as a therapy for retinal neovascularization

Published:2023-01 Issue: Volume:187 Page:106617
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Wang Jiang-Hui,Lin Fan-Li,Chen Jinying,Zhu Linxin,Chuang Yu-Fan,Tu Leilei,Ma Chenkai,Ling Damien,Hewitt Alex W.,Tseng Ching-Li,Shah Manisha H.,Bui Bang V.,van Wijngaarden Peter,Dusting Gregory J.,Wang Peng-Yuan,Liu Guei-Sheung

Publisher

Elsevier BV

Subject

Pharmacology

Reference61 articles.

1. Ocular neovascularization: clarifying complex interactions;Neely;Am. J. Pathol.,1998

2. An allosteric peptide inhibitor of HIF-1alpha regulates hypoxia-induced retinal neovascularization;Usui-Ouchi;Proc. Natl. Acad. Sci. USA,2020

3. Retinal and choroidal neovascularization;Campochiaro;J. Cell Physiol.,2000

4. Diabetic macular edema: it is more than just VEGF;Singer;F1000Res,2016

5. Mediators of ocular angiogenesis;Qazi;J. Genet.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAK1 inhibition mitigates intracerebral hemorrhage-induced brain injury through reduction of oxidative stress and neuronal pyroptosis via the NRF2 signaling pathway;Frontiers in Immunology;2024-05-02

2. TAK1 in Vascular Signaling: “Friend or Foe”?;Journal of Inflammation Research;2024-05

3. Low shear stress induces macrophage infiltration and aggravates aneurysm wall inflammation via CCL7/CCR1/TAK1/ NF-κB axis;Cellular Signalling;2024-05

4. AAV2-antiVEGFscFv gene therapy for retinal neovascularization;Molecular Therapy - Methods & Clinical Development;2023-12

5. Activation of aryl hydrocarbon receptor by azatyrosine-phenylbutyric hydroxamide inhibits progression of diabetic retinopathy mice;Biochemical Pharmacology;2023-09